Key facts
- Origin Medical’s last known valuation is $110K (Jul 2020).
- It has raised $7.6M; the latest was Mezzanine ($550K) in Sep 2025.
- Notable investors include Creative Destruction Lab, Entrepreneurs First, Village Global, Texas Medical Center, Mehdi Ghissassi — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Origin Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Origin Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Origin Medical
Developer of an AI technology designed to help clinicians perform pregnancy ultrasound scans. The company's device-agnostic technology leverages AI to assist a wide spectrum of physicians by combining the knowledge of healthcare and AI, with AI imaging workflow, clinicians can more confidently deliver timely interventions, enhance pregnancy outcomes, identify high-risk pregnancies to reduce maternal mortality, and significantly lower infant mortality rates, enabling clinicians to make necessary interventions and to provide solutions aimed at supporting healthcare providers in rural and urban communities, allowing them to practice at the top of their licenses.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2019
- Employees
- 11
- Website
- originmedical.ai/
- Ownership
- Privately Held (backing)
Origin Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Origin Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Origin Medical in its N-PORT filings yet. We sweep new filings monthly.